Oramed Signs Definitive Deal with Medicox to Commercialize Oral Insulin in South Korea

/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,Jinhae ,Kyongsang Namdo ,Kimhae ,United States ,Israel ,Republic Of Korea ,Nadav Kidron ,Zach Herschfus ,Oramed Pharmaceuticals Inc ,Mecox Curemed Co Ltd ,Company Contact ,Medicox Co Ltd ,Prnewswire Oramed Pharmaceuticals Inc ,Exchange Commission ,Oramed Pharmaceuticals Nasdaq ,Distribute Oramed ,Oral Insulin ,Market Potential ,Over Age ,Oramed Chief Executive Officer Nadav ,Medicox Chief Executive Officer Dae Hwan ,Protein Oral Delivery ,